New Delhi: An indigenous paper-strip COVID-19 diagnostic test, named after one of India’s most famous fictitious detectives ‘FELUDA’, recently received approval from the Drugs Controller General of India for a commercial rollout.
This test kit is developed by scientists at the Delhi-based Institute of Genomics and Integrative Biology, one of the CSIR institutes, would be manufactured by Tata group company in accordance with an agreement that Tata Sons signed with the CSIR institute in May.
“It received regulatory approvals today from the Drug Controller General of India (DCGI) for commercial launch, as per ICMR guidelines, meeting high-quality benchmarks with 96 per cent sensitivity and 98 per cent specificity for detecting the novel coronavirus,” said a PIB press release.
The Tata CRISPR test is the world’s first diagnostic test to deploy a specially-adapted Cas9 protein to successfully detect the virus causing COVID-19, the statement added.
Here are the interesting facts about the testing kit FELUDA:
Mumbai: Ananya Panday and Aditya Roy Kapur were one of the most talked-about couples of…
Balangir: Former MLA Jagneswar Babu, who left Congress recently, joined Bharatiya Janata Party in Odisha's…
Ayodhya: Prime Minister Narendra Modi held a grand roadshow here on Sunday evening after offering…
Puri: Congress' candidate for Puri Sadar Assembly constituency in Odisha Uma Ballav Rath was allegedly…
Bhubaneswar: A total of 115 boys and girls from Nepal, Canada, USA and host country…
New Delhi: Kishori Lal Sharma, Congress’ surprise choice for Amethi Lok Sabha constituency, said on…
Puri: The under-production Odia film 'Ashram' will be released in cinema theatres across Odisha in…
New Delhi: The Council for the Indian School Certificate Examinations (CISCE) will announce results for…